Background: Evidence for indoor airborne transmission of SARS-CoV-2 is accumulating. If SARS-CoV-2 also spreads via aerosols, this has implications for measures taken to limit transmission.Objectives: The aim of this study is to assess exposure to airborne SARS-CoV-2 particles from breathing, speaking, coughing and sneezing in an indoor environment.Methods: An exposure assessment model was developed to estimate numbers of SARS-CoV-2 particles in aerosol droplets, expelled during breathing, speaking, coughing and sneezing by an infected person in an unventilated indoor environment, and subsequent inhalation by one or more persons. Scenarios encompass a range of virus concentrations, room sizes and exposure times.Results: The calculated total volume of expelled aerosol droplets was highest for a sneeze, followed by a cough and speaking for 20 minutes, and lastly breathing for 20 minutes. A few to as much as tens of millions of virus particles were expelled. Exposure probability strongly depends on the viral concentration in mucus, as well as on the scenario. Exposure probabilities were generally below 1% at a virus concentration in mucus below 105 per mL for all scenarios, increasing steeply at different higher concentrations. According to nose / throat swab data collected from patients, 75%, 50% and 5% of infected individuals carry an estimated number of SARS-CoV-2 per mL mucus of at least 105, 106 and 108, respectively.Discussion: Exposure to SARS-CoV-2 via aerosols generated during breathing, speaking, coughing and sneezing in an unventilated indoor environment is possible. This study forms a basis to estimate probabilities of exposure to SARS-Cov-2 by airborne transmission in indoor spaces. As long as it is uncertain what fraction of the airborne virus particles is infectious and as long as a dose response relation is lacking, it is recommended to be precautious.
Between mid-September and 19 October 2008, nine clusters of norovirus infection involving around 90 primary cases and over a hundred secondary cases were identified in patients from the Netherlands, Ireland, Italy and France, linked to pilgrimage to Lourdes, France.
An increasing number of acute gastroenteritis outbreaks have been reported in the Netherlands since October 2004. The early onset of the ‘winter vomiting disease’ season and the high number of reports are unusual.
Wearing face masks is considered as one of the infection prevention and control options for respiratory viruses (e.g., SARS-CoV-2) that acts by blocking virus-laden aerosols. It is generally thought that aerosol blockage occurs when air passes through the face mask fabric. We calculated air flows through face masks and through peripheral leakages, based on reported breathing resistance values of face masks (FFP/N95, surgical masks, and cloth masks) and found that most of the inhaled and exhaled air passes through these peripheral leakages. Nevertheless, face masks remain effective as an infection prevention option, because additional calculations showed that the majority of aerosol volume cannot follow the tortuous path of air around the face mask. The filtering efficiency through the peripheral leakages can be described as a function of breathing conditions, vocal activities, the leakage geometry and tortuous pathway, aerosol properties (diameter, composition) and ambient conditions (e.g., evaporation, ventilation). Inclusion of these parameters explains the asymmetric filtering behavior of face masks, i.e., the risk of infection from person A to person B does not necessarily equal the risk of infection from person B to person A. Our findings explain thus why masking an infectious person is more effective than masking an exposed person. Establishing that the tortuous pathway of air around the face mask is the sole contributor to face mask efficiency opens new opportunities for designing safer face masks.
This observational experimental study was aimed at measuring SARS‐CoV‐2 dispersion via air and deposition onto surfaces in indoor spaces at short range (0.8 m) and long range (4.0 m) during the speaking and singing of mildly symptomatic COVID‐19 patients. Ten patients were invited to sing and speak in unventilated rooms. Air and surface samples were taken and analyzed for SARS‐CoV‐2 by qPCR and cell culture assay. Seventy‐three of 120 air samples and 2 of 80 surface samples tested positive by qPCR. Concentrations were too low to be quantified. Culturing to confirm infectivity was unsuccessful for all samples. High nasal virus concentration in patients, a high number of symptoms, and short symptom duration correlated with a higher probability of PCR‐positive air samples. Impingers were significantly more effective air samplers than impactors. No significant effect was found for patient age, oropharyngeal virus concentration, the presence of systemic symptoms, vaccination status, the number of coughs during measurements, room temperature, humidity, time, proximity, respiratory activity, or voice amplitude during experiments. Two supporting experiments were performed on aerosol dispersion and sampler equipment tests. They confirmed that aerosols spread throughout the room homogeneously and that selected sampler equipment can detect genetic material from environmental samples. This study adds to the body of evidence regarding the dispersion of SARS‐CoV‐2 RNA in range of a few meters indoors.